Peter Zdziarski/LinkedIn
Apr 13, 2026, 17:41
Peter Zdziarski: Glanzmann’s Research Foundation Listed as GT Patient Organization on NORD
Peter Zdziarski, Founder and Marketing Director of Glanzmann Thrombasthenia Advocacy Network, shared a post on LinkedIn:
“Proud to share that the Glanzmann’s Research Foundation, Inc. is now listed as a patient organization for GT on the National Organization for Rare Disorders website.
This is a meaningful step in helping more individuals and families affected by Glanzmann Thrombasthenia find trusted information and a supportive community of actual patients that much sooner.
Grateful to NORD for the work they do to elevate rare disease organizations and connect people to the resources they need.”
More posts featuring Peter Zdziarski on Hemostasis Today.
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question
-
Oct 20, 2026, 04:04Sadia Kamal: Honored to Receive the Outstanding Abstract Award at the 20th Midwest Platelet Conference
-
Oct 20, 2026, 04:03Yu-Hsuan Chen: One Antibody, Two Diseases from FcRn Biology to Clinical Translation
-
Oct 20, 2026, 03:49Domenico Simone Castiello: Rethinking Prolonged DAPT in Multivessel PCI – Insights from the DAPT-MVD Trial
-
Oct 20, 2026, 03:37Rucha Patil: Scaling POC Diagnostics for Haemophilia A and VWD Across India
-
Oct 20, 2026, 03:31Zena Vexler: Targeting Neutrophil Elastase and NETosis to Mitigate Infection-Triggered Childhood Stroke
-
Oct 20, 2026, 03:24Chaza Alaji: Diagnosing Protein C and Protein S Deficiency